Paul R. Fonteyne
Paul R. Fonteyne has spent 30+ years in the pharmaceutical industry, retiring at the end of 2018 as Chairman of Boehringer-Ingelheim USA, the US arm of Boehringer-Ingelheim, a large privately held research driven pharmaceutical company with a rich and growing portfolio of Human Pharmaceuticals, animal health products and biologics contract manufacturing. Paul was with Boehringer-Ingelheim for 15 years in leadership roles both in the US and globally. Prior to Boehringer-Ingelheim, Paul had commercial leadership roles at Merck and Co. Inc. and Abbott Laboratories. Paul holds a MS in Chemical Engineering from the University of Brussels and an MBA from Carnegie Mellon University.